| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8a6399d236ec0ea3dc12007c4c82740e |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S930-15 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-16 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-16 |
| filingDate |
1986-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1988-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7a54cb028d781d54ab68b6a116409820 |
| publicationDate |
1988-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-4717715-A |
| titleOfInvention |
ARG7 -ARG8 -vasopressin antagonists |
| abstract |
Vasopressin antagonists which have a dipeptide side chain comprised of two basic amino acids demonstrate potent V1 and V2-antagonist activity. A species of the invention, which is prepared by conventional peptide sequencing, is [1-( beta -mercapto- beta , beta -cyclopentamethylene propionic acid)-2-(O-ethyl)-D-tyrosine-4-valine-7-arginine-8-arginine-9-desglyci ne]-vasopressin. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5051400-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5990273-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004115455-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9200094-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4826813-A |
| priorityDate |
1986-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |